Tag: NUV-1511

Nuvation Bio receives FDA clearance for NUV-1511 IND in advanced solid tumors

businessnewstoday- January 9, 2024

In a significant stride for cancer treatment, Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company dedicated to addressing unmet needs in oncology, announced the U.S. ... Read More